The Hemodynamic Monitoring Systems Market is estimated to hit $2.76 billion by 2023

According to the new market research report by IndustryARC titled “Hemodynamic Monitoring Systems Market: By Product (PAC, Cardiac Output Monitoring Systems, Disposables); By Type (Minimally Invasive, Non-invasive, Invasive); By End User (Hospitals, Clinics); By Geography - Forecast(2018-2023)”, the market registers a healthy growth due to the rising ‘cardio-patient population’ along with hypertension cases across the globe.
The hemodynamic market is estimated at $1.86 billion in 2017 and is expected to reach $2.76 billion by 2023 with a CAGR of 7.5% in the forecast period. Hospitals end-user segment was estimated at $1.251 billion and expected to reach $1.754 billion by 2023 at 6.4% CAGR. Clinics which include cath labs are poised to witness the highest growth rate of 9.9% during the forecast period.

In the hemodynamics monitoring market, Americas hold the largest share with 38.08%, followed by APAC and Europe with 31.17% and 26.92% respectively. Americas is the largest market for hemodynamic monitoring systems globally with revenue of $711.3 million in 2017. This market is projected to grow to $1.07 billion by 2023, as growing health concerns and development of non-invasive hemodynamic monitoring systems propel the adoption. The APAC region is forecast to exhibit the highest growth of 8.1% through 2023 to reach $902.23 million. The rapidly aging population in Japan, combined with governmental insurance and healthcare programs are set to spur the market growth in this region.

Noninvasive Hemodynamic Monitoring To Be Come Mainstream Products:
The healthcare system has observed incessant developments, as most of the people are considering health as a vital aspect of social and psychological life. The hemodynamic/patient monitoring system is one such healthcare system that has been improved over time, to offer a better and efficient way of monitoring oxygen supply in the body. Since their inception in the market, invasive techniques have been employed for cardiac patient monitoring, but have proved to be an obstacle in case a patient needs to an immediate diagnosis, or if the body of a patient is fragile enough to handle it. Therefore, medical devices manufacturers such as Cheetah Medical and Edwards have been instrumental in devising non-invasive hemodynamic monitoring systems.

As mentioned in the above paragraph, the same trend is already visible in the non-invasive evaluation of cardiac output and its derived variables. This kind of devices relies extensively on the algorithms for estimating the variables. Although, the successive versions of algorithms are yielding reliable data, but still they are not in the limits set up by regulatory bodies. The prime example of such cases being the continuous noninvasive arterial pressure monitoring systems that have not offered any data limits in accordance with the standards set by the Association for Advancement of Medical Instrumentation. The technology for noninvasive in the current scenario is not yet advanced to meet the requisite standards, but the complications posed by invasive methods for high-risk surgery patients due to the fragile body, or in the form of thrombotic and infectious threats will swiftly move the development of non-invasive hemodynamic monitoring systems.

Electronic Health Re-Cord Integration to Offer New Growth Avenues for Hemodynamic Monitoring:
Electronic Health Record (EHR) deals with the systematic collection of the patient’s data in a digital format that can be accessed ubiquitously. This sort of access offers a real-time update of the medical condition of a patient that can be crucial for diagnosis by offering features such as modification of treatment with improved accuracy, reduction in medical errors and treatment delays, along with duplication of tests. The advent of non-invasive hemodynamic monitoring has been complemented with the integration of EHR features. Non-invasive monitoring methods provide continuous health data that can be utilized for recognizing early symptoms in the patient. This predictive outcome is entirely based on stochastic controls that identify the initiating hemodynamic mechanisms and allows for early corrections in the outcome. Although, the noninvasive techniques are yet to tap the potential in the hemodynamic monitoring, but the integration of EHR will empower the early adopters to gain a competitive edge in the market.

Excerpts on Market Growth Factors Mentioned in the Full Report:
The aging population remains one of the most important drivers which has fueled the market growth.
The demand for hemodynamic monitoring systems for treatment of chronic diseases is going to witness a positive trend in the market.
The demand for the non-invasive system which is able to measure CO, stroke and other biological parameters is going to increase dramatically. Hence, this factor is projected to propel the market growth.
With the advancements in technology, the user-friendly hemodynamic monitoring systems are being invented. With these systems invading the market, the uptake of hemodynamic monitoring systems is going to rise in an exponential manner.

Key Players of the Hemodynamic Monitoring Systems Market:
GE Healthcare, Edwards Lifesciences, Deltex Medical Sciences, Inc., Philips Healthcare and Draeger Medical Inc. are the key players in Hemodynamic Monitoring Systems market. The smaller firms contributed 45% of the total market share whereas, the top 5 companies contributed 55% of the total market share. GE Healthcare is the dominant company owing to the strong customer base and wide distribution. As the market undergoes a transformation, the advent of new players in the market will push forward innovations, which will help to deliver better and effective products to the customers. These players are introducing better equipped hemodynamic monitoring systems at competitive prices to gain an advantage over the established players.